| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,156 |
59,297 |
$3.05M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
52,743 |
24,144 |
$1.34M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14,563 |
12,070 |
$1.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,647 |
10,693 |
$836K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,688 |
9,816 |
$730K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
10,060 |
8,312 |
$707K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25,791 |
21,294 |
$650K |
| 96160 |
|
36,841 |
28,796 |
$635K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,569 |
3,620 |
$353K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,620 |
7,568 |
$249K |
| 96161 |
|
7,804 |
6,632 |
$116K |
| 96127 |
|
23,744 |
18,585 |
$102K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,182 |
3,609 |
$87K |
| 92551 |
|
10,635 |
8,539 |
$84K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
8,623 |
7,345 |
$59K |
| 99401 |
|
2,955 |
2,351 |
$58K |
| 54150 |
|
351 |
292 |
$54K |
| 99051 |
|
9,227 |
8,193 |
$41K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,301 |
2,020 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,221 |
2,027 |
$32K |
| 99460 |
|
635 |
560 |
$31K |
| 83655 |
|
2,640 |
2,057 |
$31K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
586 |
507 |
$29K |
| 3008F |
|
26,100 |
20,766 |
$26K |
| 99463 |
|
408 |
353 |
$26K |
| 99050 |
|
1,131 |
1,018 |
$22K |
| 92558 |
|
2,350 |
1,816 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
486 |
441 |
$15K |
| 99177 |
|
2,432 |
1,864 |
$14K |
| 90670 |
|
7,323 |
6,066 |
$14K |
| 87807 |
|
1,389 |
1,209 |
$14K |
| 90461 |
|
17,778 |
13,410 |
$13K |
| 96158 |
|
545 |
172 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
5,396 |
4,368 |
$11K |
| 36416 |
|
8,218 |
6,483 |
$11K |
| 99173 |
|
2,242 |
1,817 |
$9K |
| 90698 |
|
8,813 |
7,283 |
$8K |
| 90651 |
|
653 |
492 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
251 |
196 |
$6K |
| 85018 |
|
2,616 |
2,065 |
$6K |
| 90686 |
|
10,026 |
8,075 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
439 |
410 |
$5K |
| 81003 |
|
2,271 |
1,886 |
$4K |
| 90680 |
|
5,107 |
4,269 |
$4K |
| 90677 |
|
1,462 |
1,206 |
$4K |
| 88720 |
|
890 |
583 |
$4K |
| 0001A |
|
96 |
70 |
$3K |
| 0002A |
|
92 |
69 |
$3K |
| 99383 |
|
53 |
27 |
$3K |
| 99215 |
Prolong outpt/office vis |
39 |
28 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
85 |
85 |
$3K |
| 90716 |
|
521 |
389 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
179 |
153 |
$3K |
| 3078F |
|
513 |
212 |
$2K |
| 3074F |
|
511 |
211 |
$2K |
| 90734 |
|
409 |
325 |
$2K |
| 80061 |
Lipid panel |
152 |
126 |
$2K |
| 0031A |
|
67 |
46 |
$2K |
| 99384 |
|
18 |
13 |
$2K |
| 90707 |
|
523 |
398 |
$2K |
| 90633 |
|
2,235 |
1,831 |
$2K |
| 88738 |
|
361 |
266 |
$2K |
| 96159 |
|
125 |
42 |
$1K |
| 96380 |
|
58 |
44 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$927.91 |
| 0072A |
|
23 |
14 |
$817.76 |
| 90710 |
|
90 |
68 |
$787.11 |
| 0071A |
|
23 |
14 |
$760.01 |
| 90619 |
|
73 |
50 |
$701.06 |
| 90672 |
|
632 |
572 |
$630.33 |
| 90744 |
|
2,824 |
2,327 |
$623.25 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
13 |
$526.92 |
| 90656 |
|
592 |
503 |
$377.67 |
| 90696 |
|
76 |
55 |
$181.65 |
| 90715 |
|
98 |
74 |
$157.77 |
| 90660 |
|
85 |
77 |
$98.70 |
| 82272 |
|
34 |
25 |
$91.12 |
| 82962 |
|
19 |
12 |
$58.30 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
91 |
80 |
$49.36 |
| 90674 |
|
499 |
380 |
$28.44 |
| 90685 |
|
459 |
409 |
$24.78 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
75 |
67 |
$9.60 |
| 99072 |
|
4,281 |
3,407 |
$4.99 |
| 91300 |
|
311 |
226 |
$0.45 |
| 91307 |
|
133 |
89 |
$0.30 |
| 91303 |
|
65 |
45 |
$0.12 |
| 90381 |
|
17 |
17 |
$0.01 |
| 90661 |
|
36 |
28 |
$0.00 |
| 99000 |
|
6,221 |
5,619 |
$0.00 |